Metraipolis › archive › dc_889a45f285d9
Tixagevimab-Cilgavimab Effectively Prevents COVID-19 Infection in Patients with End-Stage Kidney Disease — Europe PMC PMID:41012644
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41012644
- DOI
- 10.3390/v17091216
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T02:23:21.688Z
- SHA-256 of the archived text
f7f9f437b9f78ed30b165a0102b29aad28cf8284918c66fb6e305b89161dfb32- Stable URL of this page
https://metraipolis.com/documento/dc_889a45f285d9
How to cite
Tixagevimab-Cilgavimab Effectively Prevents COVID-19 Infection in Patients with End-Stage Kidney Disease — Europe PMC PMID:41012644 — Europe PMC (en), https://europepmc.org/article/MED/41012644 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_889a45f285d9 (Metraipolis archive dc_889a45f285d9, sha256 f7f9f437b9f78ed30b165a0102b29aad28cf8284918c66fb6e305b89161dfb32)
BibTeX
@misc{dc889a45f285d9,
title = {Tixagevimab-Cilgavimab Effectively Prevents COVID-19 Infection in Patients with End-Stage Kidney Disease — Europe PMC PMID:41012644},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41012644},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_889a45f285d9; sha256 f7f9f437b9f78ed30b165a0102b29aad28cf8284918c66fb6e305b89161dfb32},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41012644. Agents can read the archived copy with the MCP tool read_document.